An orally available non-nucleotide STING agonist with antitumor activity

Pan, Bo-Sheng, Perera, Samanthi A., Piesvaux, Jennifer A., Presland, Jeremy P., Schroeder, Gottfried K., Cumming, Jared N., Trotter, B. Wesley, Altman, Michael D. +33 more·2020·Science

DOI 10.1126/science.aba6098

Cited by (709)

Items 401–500 of 709

Engineering nanomedicine for STING pathway activation: Advancing cancer immunotherapy
Zhilin Li, Hongbin Zhang, Qiyong Gong, Kui Luo · 2026 · Journal of Controlled Release
Identification of an STING inhibitor targeting the allosteric transmembrane domains
Qingxuan Chen, Ancheng Shen, Xinyi Shi, Tailiang Lin, Qinghua Wang, Zhen Wang, Xuekui Yu, Buyong Ma, Chunyong Ding, Ao Zhang · 2026 · Cell chemical biology
Immune Regulation by Cytosolic DNA Sensors in the Tumor Microenvironment
Keitaro Fukuda · 2023 · Cancers
Polymeric STING Pro‐agonists for Tumor‐Specific Sonodynamic Immunotherapy
Jie Yu, Shasha He, Chi Zhang, Cheng Xu, Jingsheng Huang, Mengke Xu, Kanyi Pu · 2023 · Angewandte Chemie
In Situ Aggregated Nanomanganese Enhances Radiation-Induced Antitumor Immunity
Jialong Xu, Chao Wang, Liang Zhang, Chuan Zhao, Xiaozhi Zhao, Jinhui Wu · 2024 · ACS Applied Materials & Interfaces
Intratumoral cancer immunotherapy exploiting anti-viral immunity
Norimitsu Kadowaki · 2021 · Journal of the Japan Society of the Reticuloendothelial System
Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
Bingteng Xie, Aiqin Luo · 2022 · Frontiers in Cell and Developmental Biology
Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity
Michael C. Brown · 2022 · Cancer treatment and research
Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists
Xue Liu, Mingjin Wang, Minjian Yang, Hanyu Sun, Baolian Wang, Xiandao Pan, Xiaoguang Chen, Jing Jin, Xiaojian Wang · 2022 · European Journal of Medicinal Chemistry
Cyclic diguanylate analogues: Facile synthesis, STING binding mode and anti-tumor immunity delivered by cytidinyl/cationic lipid
Xudong Sun, Xiaotong Yu, Yaqi Zhao, Lei Xing, Luxin Na, Zhuo Chen, Zhangping Xiao, Hong Dai, Jing Yu, Sijie Long et al. · 2022 · European Journal of Medicinal Chemistry
Parallels Between the Antiviral State and the Irradiated State
Heather M. McGee, Ariel E. E. Marciscano, Allison M. Campbell, Arta Monir Monjazeb, Susan M. Kaech, John Ross Teijaro · 2020 · JNCI Journal of the National Cancer Institute
Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report
Wei Yang, Yeke Zhang, Gaoyi Yang, Geng Yanhua, Da Chen, Jun Wang, Yang Ye, Huaichong Wang, Dajing Xia, Fuliang Hu et al. · 2021 · Frontiers in Oncology
Lipid nanoparticles delivering constitutively active STING mRNA as a novel anti-cancer therapeutic approach
Wei Liu, Mohamad‐Gabriel Alameh, June F. Yang, Jonathan R. Xu, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Jianxin You · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Development of STING probes and visualization of STING in multiple tumor types
Huanhuan Liu, Jia Liu, Yingxi Chen, Hongzhang Yang, Jianyang Fang, Xinying Zeng, Jingru Zhang, Shilan Peng, Yuanyuan Liang, Rongqiang Zhuang et al. · 2024 · European Journal of Nuclear Medicine and Molecular Imaging
Discovery of STING antagonists targeting cGAS-STING pathway to alleviate IMQ-induced psoriasis-like dermatitis
Zhixiong Zhang, Xian Wei, Qiang Huang, Zhonghua Shi, Xiaofeng Chen, Jialin Wu, Xin Wang, Jiaqi Li, Lantu Gou, Jinliang Yang · 2025 · European Journal of Pharmaceutical Sciences
IRF1 amplifies HSV-1-triggered antiviral innate immunity in a feed-forward manner
Ming Gao, Yining Qi, Junjie Zhang · 2025 · Cell Insight
A lyophilizable LNP vaccine enables STING-reinforced postoperational adjuvant immunotherapy
Yi Yang, Jiaxin Guo, Jialong Qi, Wenxia Deng, Jialin Hu, Muhammad Waqqas Hasan, Fei Deng, You Lian Zhou, Zhengji Song, Wei Deng et al. · 2025 · Journal of Nanobiotechnology
cGAS–STING: From immunology and oncology view
Xiangxiang Liu, Chengshi Ding, Jun Lü, Na Zhang · 2025 · Chinese Medical Journal
Dual-receptor targeting of type I dendritic cells with DNA-scaffolded nanoparticles enhances STING-licensed antitumor immunity
Deblin Jana, Emilia Herdes, Justin Moustouka, Kayla M. Mash, Jingge Chen, Kareem Ebeid, Marwa A. Sallam, Akram Abbasi, Tejal Ashwin Desai · 2026 · Science Advances
MnO2-passivated Co3O4 sonozymes for tumor microenvironment re-activated sonodynamic and chemodynamic enhanced immunotherapy
Qiwei Zhou, Jie Wang, Lin Li, Jiwen Hu, Da Xu, Wenliang Gong, Cheng Fei, Fangzhi Liang, Haopeng Liu, Bijiang Geng et al. · 2026 · Biomaterials
Structure–Activity Relationship Study of 1H-Pyrrole-3-carbonitrile Derivatives as STING Receptor Agonists
Chang Shen, Peijia Xu, Changfa Zhang, Zhaoming Su, Bin Shan, Rui Li, Qibang Sui, Keke Zhang, Zhengyang Chen, Jingyi Zhou et al. · 2023 · ACS Medicinal Chemistry Letters
A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling
Melissa Dolan, Yuhao Shi, Michalis Mastri, Mark D. Long, Amber McKenery, James W. Hill, Cristina Vaghi, Sébastien Benzekry, Joseph J. Barbi, John M.L. Ebos · 2024 · Molecular Cancer Therapeutics
Fabrication of RIG-I-Activating Nanoparticles for Intratumoral Immunotherapy via Flash Nanoprecipitation
Payton T. Stone, Alexander J. Kwiatkowski, Eric W. Roth, Olga Fedorova, Anna Marie Pyle, John T. Wilson · 2025 · Molecular Pharmaceutics
Non-canonical roles of apoptotic and DNA double-strand break repair factors in mediating cellular response to ionizing radiation
Chuan‐Yuan Li · 2021 · International Journal of Radiation Biology
Unexpected Breg-NK crosstalk in STING agonist therapy
Yunke Wang, Anne E. Geller, Jun Yan · 2022 · Cellular and Molecular Immunology
Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy
Xiaoyan Qi, Cheng Cheng, Dawei Zhang, Zongjiang Yu, Xiangwei Meng · 2024 · Frontiers in Immunology
Macrophage membrane-engineered biomimetic nanoplatform to potentiate STING pathway-mediated tumor immunotherapy
Kaixuan Zhang, Yanhao Qu, Jie Li, Shaomin Wang, Liting Yang, Suzhen Wang, Yuxia Luan · 2025 · Chemical Engineering Journal
Near-infrared light-induced photothermal and immunotherapy system for lung cancer bone metastasis treatment with simultaneous bone repair
Guoqing Zhong, Yali Miao, Jielong Zhou, Yijie He, Wenjie Yang, Chongquan Huang, Yunhui Zhang, Jin Xiao, Bingqing Bai, Jiaqi Zhou et al. · 2025 · Bioactive Materials
cGAS Inhibits ALDH2 to Suppress Lipid Droplet Function and Regulate MASLD Progression
Ying Wang, Yu Deng, Jianfeng Chen, Quentin Hahn, David S. Umbaugh, Zhigang Zhang, Yanqiong Zhang, Sarah E. Rowe, Lupeng Li, Laura E. Herring et al. · 2025 · Advanced Science
The cGAS–STING pathway in tumor immunity: dual roles, regulatory mechanisms, and precision therapeutic strategies
H B Jiang, Zhanzhan Li, X X Li, Lulu Yu, Jiacheng Sun, Yuntian Shen, Hualin Sun, Lei Qi · 2026 · Frontiers in Pharmacology
18F-Labeled Amidobenzimidazole Analogue for Visualizing STING Expression in Tumor
Jianyang Fang, Jingru Zhang, Lingxin Meng, Huifeng Li, Dongsheng Xia, Yaoxuan Wang, Hao Chen, Zhenhuan Liao, Rongqiang Zhuang, Yesen Li et al. · 2024 · Molecular Pharmaceutics
Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging
Jianyang Fang, Xiaobo Wang, Lingxin Meng, Jingru Zhang, Rongqiang Zhuang, Yesen Li, Xianzhong Zhang, Zhide Guo · 2024 · ACS Pharmacology & Translational Science
Stage-specificity of STING activation in intrahepatic cholangiocarcinoma determines the efficacy of its agonism
Shengnan Luo, Shun Li, Caiqi Liu, Dongyu Yu, Linlin Sun, Shuyuan Zhang, Na Zhao, Meng Zhang, Jianhua Nie, Ying Zhao et al. · 2024 · Cancer Letters
[1,2,4]Triazolo[1,5-a]pyrimidine derivatives: Structure-activity relationship study leading to highly selective ENPP1 inhibitors
Mitsuyasu Kawaguchi, Shohei Minami, Naoya Ieda, Hidehiko Nakagawa · 2024 · Bioorganic & Medicinal Chemistry Letters
Au naturale: use of biologically derived cyclic di-nucleotides for cancer immunotherapy
Christopher M. Waters · 2021 · Open Biology
Discovery of novel amidobenzimidazole derivatives as orally available small molecule modulators of stimulator of interferon genes for cancer immunotherapy
Min Jae Jeon, Hyelim Lee, Seongman Jo, Miso Kang, Jeong Hyun Jeong, So Hyeon Jeong, Joo‐Youn Lee, Gyu Yong Song, Hyunah Choo, Sanghee Lee et al. · 2023 · European Journal of Medicinal Chemistry
A Non-Nucleotide STING Agonist MSA-2 Synergized with Manganese in Enhancing STING Activation to Elicit Potent Anti-RNA Virus Activity in the Cells
Hanrui Lin, Rui Zhang, Hanyi Xiang, Xinqian Lin, Xiongting Huang, Jingsong Chen, Long Zhou, Zhidong Zhang, Yanmin Li · 2023 · Viruses
Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression
Jun Xu, Nicolas Solban, Yun Wang, Heidi M. Ferguson, Samanthi A. Perera, Ken Yu Lin, Mingmei Cai, Paul L. Miller, Ernest G. Schutt, Clayton T. Larsen et al. · 2021 · Advanced Therapeutics
Microbiota-derived secondary bile acids promote STING activation and antitumor activity
Xinglin Yang, Xing Zhang, Weichao Li, Anant Gharpure, Althea Hansel-Harris, Yan-Zhu Hsieh, Stanislav Dikiy, Andreas F. Tillack, Chongyang Wu, Ariana Sulpizio et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Interferon signaling and STING pathway in head and neck cancers: unlocking immune secrets and therapeutic frontiers
Kosar Zolfaghari, Mohammad Yazdi, Shaghayegh Mohammadioun, Fatemeh Tajafrooz, Hesam Malekfarnood, Kiarash Saleki, Nima Rezaei · 2025 · Cancer Cell International
Promoting Endogenous Danger Signals Accumulation by a Hierarchical Nanoinducer for Amplifying STING Pathway Activation-Mediated Tumor Immunotherapy
Xiao‐Kang Jin, Shi‐Man Zhang, Zihan Xu, Hong Chen, Jun‐Long Liang, Xiao Yan, Chuan‐Jun Liu, Xian‐Zheng Zhang · 2025 · ACS Nano
An Immune Nanoenhancer Revitalizes Chemotherapeutics to Tailor Tumor‐Derived dsDNA for Anticancer Immunoengineering
Ying Liu, Yachao Li, Wensheng Gong, Dongzhe Zou, Beiling Guo, Zenan Zeng, Xiaoxiao Li, Yini Xu, Xianghui Xu · 2025 · Advanced Materials
Co-delivery of a STING agonist and indoleamine 2,3-dioxygenase 1 blockade activates type I dendritic cells in cancer
Yanming Xia, Lixin Hu, Yuhan Hu, Shihao Wang, Qingqing Xiong, Xing Wang, Y Li, Lifang Yin, Jian Wang, Suxin Li · 2026 · Journal of Controlled Release
PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunity
Ye Liu, Maolin Jiang, Mengchao Ding, Ihsan Ullah, Haiyang Wang, Wenjiao Xie, Kewei Wang, Youyong Yuan · 2026 · Science Advances
Feedback activation of CD73-Adenosine axis attenuates the antitumor immunity of STING pathway
Nannan Fu, Ziang Zhang, Junmin Quan · 2024 · Biochemical and Biophysical Research Communications
Pharmacological potential of cyclic nucleotide signaling in immunity
Eirene Marie Q. Ednacot, Ali Nabhani, David M. Dinh, Benjamin R. Morehouse · 2024 · Pharmacology & Therapeutics
A non-lipid nucleic acid delivery vector with dendritic cell tropism and stimulation
Hyung Shik Kim, Elias A. Halabi, Noah Enbergs, Rainer H. Köhler, Fan Fei, Christopher Garris, Ralph Weissleder · 2024 · Theranostics
Macrophage crosstalk and therapies: Between tumor cells and immune cells
Cheng-Yuan Fan, Jing-Sen Zheng, Lian‐Lian Hong, Zhi‐Qiang Ling · 2024 · International Immunopharmacology
Design, Synthesis, and Biological Evaluation of Selective STING Synergists That Enhance cGAMP-STING Pathway Activation without Inherent Agonist Activity
Shi Xiang Hou, Jiajia Chang, Cheng Xing, Ze Ye, Wei Li, Ying Zhang, Zhibing Zheng, Junhai Xiao, Song Li · 2025 · Journal of Medicinal Chemistry
Synergistic Activation of the STING Pathway via a Mn(II)-Cross-Linked Gel Scaffold To Boost Antitumor Immunotherapy
Jiawei Yuan, Jingjing Du, Zixuan Wang, Lihui Ren, Shangwen Zhang, Muhan Chen, Jun Jie Yang, Shu Wei, Jiayun Xu, Hongcheng Sun et al. · 2025 · ACS Applied Materials & Interfaces
Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues
Yuta Yanase, Genichiro Tsuji, Miki Nakamura, Norihito Shibata, Yosuke Demizu · 2022 · International Journal of Molecular Sciences
A novel STING agonist with systemic and durable anti‐tumour activity
Xiyuan Wang, Ancheng Shen, Yan Zhang, Xiaoxu Chen, Jian Ding, Ao Zhang, Meiyu Geng, Chunyong Ding, Zuoquan Xie · 2023 · Clinical and Translational Discovery
Development of a light-activated STING agonist
Steven E. Caldwell, Chasity P. Janosko, Alexander Deiters · 2023 · Organic & Biomolecular Chemistry
STING agonist, SMA-2, inhibits clear cell renal cell carcinoma through improving tumor microenvironment
Wei J. Wang, Fengqing Zhang, Yan Hu, Guang‐Ming Liu · 2024 · Molecular and Cellular Biochemistry
Exploring nucleotide and non-nucleotide cGAS-STING agonists: Therapeutic applications and future directions in cancer immunotherapy
Abhishek Ghara, Gurubasavaraja Swamy Purawarga Matada, Payel Pramanick, Uday Raj Sharma, Prasad Sanjay Dhiwar · 2025 · Drug Discovery Today
Expression of a STING Gain-of-function Mutation in Endothelial Cells Initiates Lymphocytic Infiltration of the Lungs
Kevin MingJie Gao, Kristy Chiang, Filiz T. Korkmaz, Harish Palleti Janardhan, Chinmay M. Trivedi, Lee J. Quinton, Sébastien Gingras, Katherine A. Fitzgerald, Ann Marshak‐Rothstein · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Reproductive safety of STING agonists MSA-2 and manganese-MSA-2
Ya Cai, Tian He, Tao Yang, Yating Li, Lirong Yi, Wenqing Li, Peng Zhou · 2024 · Toxicology Research
Targeting immune checkpoint therapy: The role of manganese in tumor immunotherapy
Xingyao Lyu, Bixia Li, Zhijie Lin · 2025 · Cancer Pathogenesis and Therapy
Rational design of metal-based nanodrugs for cGAS-STING pathway activation: mechanisms, combinatorial therapies, and clinical translation
Dian Chen, Aoyu Liu, Zirui Wang, Chunting Wang, Jingjing Hu, Dengbin Wang, Defan Yao · 2026 · Coordination Chemistry Reviews
γ‐Butyrolactone Derivatives of MSA‐2 are STING Prodrugs
Kelton Alexander Schleyer, Elias A. Halabi, Ralph Weissleder · 2024 · ChemMedChem
Oligomerization of STING and Chemical Regulatory Strategies
Xi Chen, Shao‐Hua Zhuo, Yanmei Li · 2025 · ChemBioChem
Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination
Peng Zhou, Mo Wang, Tian He, Ya Cai, Yuhang Zhang, Guishuan Wang, Fei Sun, Guoqi Song, Wenqing Li · 2025 · ACS Applied Materials & Interfaces
STING and metabolism-related diseases: Roles, mechanisms, and applications
Zhengyang Zhang, Xirui Wang, Chuangchuang Zhao, Haitao Zhu, Xiang Liao, Hsiang‐i Tsai · 2025 · Cellular Signalling
Diterpenoids and diarylheptanoids from the fruits of Alpinia zerumbet and their anti-inflammatory activity
Zhenghan Zhang, Guangzhao Li, Xin Luo, Fang Xiao, Yan Zhang, Chunping Tang, Bintao Hu, Zuoquan Xie, Sheng Yao, Yang Ye · 2025 · Fitoterapia
Synthesis and Biological Activity of Benzoselenazole and Benzo[b]Selenophene Analogues: A Review
Jia Li, Jingmin Chen, Jiayao Liu, Xu-Dong Zhou, Yangyang Li, Wei Wang, Wenbing Sheng · 2025 · Drug Development Research
The human STING agonist E7766 induces immunogenic tumor clearance, independent of tumor-intrinsic STING expression in the KRAS G12D/+ Trp53 −/− murine model of sarcoma
Karys M. Hildebrand, Kurt Hildebrand, Carolina Salazar Arcila, Kayla Marritt, Jahanara Rajwani, Golpira Elmi Assadzadeh, Antoine Dufour, Frank Robert Jirik, Michael J. Monument · 2025 · OncoImmunology
Advances in STING Pathway Modulation for Cancer and Immunotherapy: A Comprehensive Review of Preclinical and Clinical Studies (2020–2024)
Rahaman Shaik, Komal Suthar, Chandrika Balija, Shifa Aleem, Fatima Sarwar Syeda, Sana Syeda, Shireen Begum · 2025 · Cancer Biotherapy and Radiopharmaceuticals
Nanoengineering of cyclic dinucleotide‑manganese complexes using biodegradable mesoporous silica nanoparticles for cancer metallo-immunotherapy
Isra Rana, Zhengzheng Zhang, Somy Yoon, Kai Han, James Jaehyun Moon, Sejin Son, Jutaek Nam · 2025 · Journal of Controlled Release
cGAS-STING signaling: a therapeutic target in inflammatory bowel disease and related colorectal cancer
Xi Chen, Xiaohua Tang, Sixuan Chen, Yang Ye, Fei Mao · 2026 · Frontiers in Immunology
ISGylation prevents autophagic degradation of STING and promotes antitumor immunity in lung cancer
Dan Cao, Huang Bin, Xinming Fu, Ming Liu, Xiaogang Niu, Hongbin Zhai, Hao Huang · 2026 · Cell Death and Disease
cGAS-STING pathway in lung cancer and emerging therapeutic approaches
Anuva Joshi, Enver Çagrı Izgü · 2026 · Drug Discovery Today
A hybrid nanoadjuvant cascading activation of the cGAS-STING-IFN-Ⅰ pathway to enhance radio-immunotherapy
Zhaohui Jiang, Pengfei Zhang, Guangzu Cui, Yongting Liu, Xinwen Wang, Zaigang Zhou, Jiang Fei, Kailing Wang, Yin Li, Xiangyang Zhang et al. · 2026 · Biomaterials
Context-dependent rewiring of the cGAS-STING pathway in cancer: Implications for immunotherapy and therapeutic resistance
Sidra Majaz, Ashfaq Ahmad, Dongsheng Liu, Aziz Ud-Din, Ikramullah khan, Yu Cui, Yingqiu Xie · 2026 · Critical Reviews in Oncology/Hematology
Therapeutic targeting of the cGAS-STING pathway in human disease
Akanksha S. Mahajan, Connor M. Forsyth, Cao Dai Phung, Xinhe Shen, Rachel Jarvis, Alexander H. Stegh · 2026 · Journal of Clinical Investigation
Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches
Emily P. Vonderhaar, Michael B. Dwinell, Brian T. Craig · 2023 · Frontiers in Immunology
Polypeptide agonists of innate immune sensors
Michelle Z. Dion, Natalie Artzi · 2024 · Nature Biomedical Engineering
Anti-inflammatory germacrane-type sesquiterpene lactones from Vernonia sylvatica
Min Wang, Han LI, Bintao Hu, Chunping Tang, Hui XU, Chang‐Qiang Ke, Zuoquan Xie, Yang YE, Sheng Yao · 2024 · Chinese Journal of Natural Medicines
Cancer Immunotherapy: Targeting TREX1 Has the Potential to Unleash the Host Immunity against Cancer Cells
Karim Hawillo, Samira Kemiha, Hervé Técher · 2024 · Onco
Profile of STING agonist and inhibitor research: a bibliometric analysis
Xuemei Wang, Qian Wang, Yidan Gao, Lijuan Jiang, Lingli Tang · 2025 · Frontiers in Pharmacology
Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8 + T Cells
Zebo Jiang, Qiang He, Liping Kang, Sha Jiang, Jiani Liu, Cong Xu, Wenjun Wang, Xuan‐Run Wang, Qibiao Wu, Donghui Huang · 2025 · Chemical Biology & Drug Design
Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model
Lenore Monterroza, Maria M. Parrilla, Sarah G. Samaranayake, Dormarie E. Rivera-Rodriguez, Sung Bo Yoon, Ramireddy Bommireddy, Justin Hosten, Luisa Cervantes Barragan, Adam I. Marcus, Brian S. Dobosh et al. · 2024 · International Journal of Molecular Sciences
Chemoproteomics of microbiota metabolites reveals small-molecule agonists for orphan receptor GPRC5A
Xiaohui Zhao, Kathryn R. Stein, Victor Chen, Matthew E. Griffin, Howard C. Hang · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Conjugated STING-agonist nanoparticles enhance antitumor immunity in multiple tumor models
Pere Dosta, Alexander M. Cryer, Michelle Z. Dion, Tsubasa Shiraishi, Steven Langston, David P. P. Lok, Jianing Wang, Sean Harrison, Shiran Ferber, Santhosh Kalash Rajendrakumar et al. · 2022 · Research Square
Synthesis and structure-activity evaluation of a series of novel tricyclic STING activators
Sourav Basu, Sandip Middya, Ritesh Shrivastava, David C. Pryde, Rajib Ghosh, Dharmendra B. Yadav, Monali Banerjee, Arjun Surya · 2025 · European Journal of Medicinal Chemistry
Low-dose inhalable amino acid-modified multilamellar nanoparticles activate STING for safe and effective regression of lung metastases
Ruoshi Zhang, Chengcheng Wu, Lvshan Yu, Cheng Peng, Sai Li, Rui Kuai · 2025 · Journal of Controlled Release
Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies
Dengjie Ouyang, Ruixian Chen, Haitong Xie, Xiwen Yang, Qintong Li, Jie Chen · 2025 · Acta Pharmaceutica Sinica B
Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy
Laura Sneller, Keshav Mathur, Shyam Kottilil, Poonam Mathur · 2025 · Viruses
PRV gD-Based DNA Vaccine Candidates Adjuvanted with cGAS, UniSTING, or IFN-α Enhance Protective Immunity
Xinqi Shi, Shibo Su, Yongbo Yang, Liang Meng, Wei Lyn Yang, Xinyu Qi, Xuyan Xiang, Yan‐Dong Tang, Cai XueHui, Haiwei Wang et al. · 2025 · Pathogens
Phosphorescent iridium complexes activated by endogenous zinc as a mitochondrial DNA nuclease for stimulation of the cGAS-STING pathway
Zhiyuan Li, Long‐Bo Yu, Qing‐Hua Shen, Liang Hao, Peng Wang, Xiaoxiao Chen, Yu‐Yi Ling, Cai‐Ping Tan · 2025 · Chemical Science
Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber · 2026 · Molecular Oncology
MITA/STING-driven CD38 induction in Siglec-Flow macrophages promotes regulatory T cell survival and non-small cell lung cancer progression
Zhi-Dong Zhang, Yu-Lin Lin, Han-Yue Zhang, Cong Zuo, Zhong-Lin ZHU, Xing-Yuan Wang, Hao-Yu DUAN, Junjie Zhang, Dandan Lin, Bo Zhong · 2026 · Developmental Cell
The cGAS-STING pathway in fibroblast microenvironment: from molecular mechanisms to targeted therapies
Zhe Zhang, Huidan Deng, Xiyuan Zhang, Jiayan Li, Jianyi Zhao, Junyang Liu, Chao Deng, Yan Yang, Zhenxing Liang · 2026 · APOPTOSIS
Protein corona-guided delivery of dextran-PLGA NPs for enhanced dendritic cell uptake, maturation and improved cancer immunotherapy
An Thi Thanh Vu, Prabhat Shrestha, Thu-Huyen Le Thi, Anil Giri, Khang‐Yen Pham, Thoa Thi Kim Nguyen, Jinkyung Cho, Seho Kweon, Na Kyeong Lee, In‐Sun Hong et al. · 2026 · Journal of Controlled Release
MSA-2 Loaded Three-Dimensional Metal Covalent Organic Framework for Synergistic Radiosensitization and Innate Immune Activation
Wenyao Zhen, Wang‐Kang Han, Tianzhi Zhao, Rebeka Rita Reszegi, Zhenni Wei, Zhi‐Guo Gu, Jingjing Zhang, Xiaoyuan Shawn Chen · 2026 · Journal of the American Chemical Society
Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic Dyad
Sandeep Atla, Veerabhadra R. Vulupala, Yugendar R. Alugubelli, Lauren R. Blankenship, Kai S. Yang, Satyanarayana Nyalata, Kaustav Khatua, Demonta D. Coleman, Dorsa Rabie, Xuejiao Guo et al. · 2026 · Journal of the American Chemical Society
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer
Christopher I. Li, Fang Ke, Hongyi Zhao, Shuai Mao, Mahamadou Djibo, Linqi Huang, Miao He, Meilin Wang, Hanning Wen, Zhongwei Liu et al. · 2026 · Nature Cancer
Recent progress in cGAS–STING agonist design and mechanisms of cancer immune modulation
L Wang, Muhammad Nafees, He Fei, Muhammad Hanif, Piaoping Yang · 2026 · RSC Chemical Biology
Rational design of carbazole-based STING inhibitors for treating cGAS-STING pathway-driven inflammatory disorders
Hui Li, Wei Zheng, Wenjing Bian, M T Li, Zhidan Fan, Ziwen Feng, X Q Liu, Shiduo Zhang, Haohao Lu, Yinquan Huang et al. · 2026 · Nature Communications
The mutational landscape of STING-induced immunity
Bing Zhang, Pengbiao Xu, Yu Meng, Laure Gallay, François Lestelle, Hélène Morel, Marie‐Louise Frémond, Bruno E. Correia, Andrea Ablasser · 2026 · Nature
Advances in structure-guided mechanisms impacting on the cGAS–STING innate immune pathway
Kexin Chen, Jialing Liao, Dinshaw J. Patel, Wei Xie · 2023 · Advances in immunology